| CAT # | Product Name | Description |
| CPDB1639 | ABBV-744 | ABBV-744 is a BDII-selective BET bromodomain inhibitor that is being investigated to treat AML and metastic castration-resistant prostate cancer. |
| CAT # | Product Name | Description |
| CPDB1639 | ABBV-744 | ABBV-744 is a BDII-selective BET bromodomain inhibitor that is being investigated to treat AML and metastic castration-resistant prostate cancer. |